Hydroxyethylstarches (HES) are used increasingly as plasma expanders in medical applications. The HES' circulation time in the blood depends strongly on its molar mass distributions. Historically, polysaccharide characterization by Gel Permeation Chromatography (GPC) has been problematic, especially
Hydroxyethylstarches (HES) are used increasingly as plasma expanders in medical applications. The HES' circulation time in the blood depends strongly on its molar mass distributions. Historically, polysaccharide characterization by Gel Permeation Chromatography (GPC) has been problematic, especially
if high molar mass components are present. Due to its superior separation capability, especially on molecules exceeding 50kDa, Flow Field-Flow Fractionation (Flow-FFF) is an excellent separation alternative. By coupling this technology to a Multi Angle Light Scattering (MALS) detector, such as a DAWN or miniDAWN, absolute values can be determined without making any assumptions.
We characterized 0.2% (w/v) HES solutions in doubly-distilled water. The HES types were 200/0.5, 130/0.42 and 70/0.5 from Serumwerk Bernburg, Germany. The FFF system was an Eclipse connected to a DAWN EOS and an RI detector (Shodex 101). Volumes of 100 μl were injected into the 350 μm spacer channel containing a 10kDa regenerated cellulose membrane. A channel flow of 1 ml/min was kept constant while the cross flow decreased linearly from 2 ml/min to 0 ml/min within 20 min. Data were evaluated using Wyatt's ASTRA software package.
Figure 1: The fractograms of the three samples with their molar mass values overlaid.
The aF-FFF/MALS fractograms of the HES types are compared in Figure 1. Corresponding to normal mode Flow-FFF theory, samples with smaller average molar mass elute faster. In Figure 2 the molar mass distributions are given as cumulative weight fraction plots. As is evident in the plots, monomodal distributions were successfully achieved. The values covered a range from approximately 20kDa to approximately 600kDa and up to 2GDa in size, depending on the characterized HES type. Thus, the average molar mass value was mainly influenced by high molar mass fractions. This was also indicated by higher polydispersity values for HES types with higher molar mass.
Figure 2: Three different HES samples shown on the cumulative weight fraction plot of ASTRA, indicating the large differences among them.
Asymmetrical FFF/MALS is, therefore, an excellent method for characterizing medical polysaccharides such as HES. The main advantage of this technique is that molar mass distributions can be determined from absolute values over an extremely wide range of masses.
This note graciously submitted by C. Augsten, K. Mäder, Institute of Pharmaceutics and Biopharmaceutics of the University Halle, W.-Langenbeck-Str. 4, 06120 Halle/Saale, Germany.
DAWN® , miniDAWN® , ASTRA® , Optilab® , and the Wyatt Technology logo are registered trademarks of Wyatt Technology Corporation.
Wyatt Technology Corporation
6300 Hollister Avenue, Santa Barbara, CA 93117
tel. (805)681-9009, fax (805)681-0123
Website: www.wyatt.com
Direct Analysis of Class 2 Residual Solvents Using Molecular Rotational Resonance Spectroscopy
February 19th 2025Molecular rotational resonance (MRR) spectroscopy operates in the microwave region, detecting transitions between pure rotational energy levels. Combined with adiabatic cooling, MRR produces highly selective spectra unique to each molecule’s atomic structure. Even slight changes in atomic position or mass result in distinct spectral differences, allowing MRR to directly analyze complex mixtures, including isomers, without chromatographic separation. This article presents a continuous headspace-MRR method for analyzing Class 2 residual solvents, including low-volatility solvents from Class 2 Mixture C. By evaluating solvents with diverse boiling points, the study demonstrates that MRR meets ICH and USP standards for most Class 2 and Class 3 solvents and half of Class 1 solvents.
Revolutionizing LC-MS with Next-Gen Separation for Cyclic Peptide Analysis
February 17th 2025Cyclic peptides, known for their stability and high specificity, are promising therapeutic agents in the fight against cancer, infections, and autoimmune diseases. However, developing effective cyclic peptides presents numerous challenges, including poor pharmacokinetics, efficacy, and toxicity. Traditional methods like liquid chromatography tandem-mass spectrometry (LC-MS/MS) often struggle with resolving isomeric linear peptide metabolites, posing significant risks in safety, efficacy, and regulatory approval. In this paper, Komal Kedia, PhD, will share how she leveraged MOBIE’s high-resolution ion mobility-mass spectrometry (IM-MS) system to achieve a 72% reduction in run times, 200% greater resolving power, and enhanced accuracy in identifying “soft spots” prone to enzymatic degradation.